Fighting Disease | Public

Fighting Disease

As humans have evolved so has our capacity to fend off and prevent diseases that threaten our wellbeing. From existing diseases like cancer—which stands to affect nearly 40% of people at some point in their lifetimes—to emerging viruses like COVID-19, public companies remain tireless in their pursuit for a cure. This theme includes disease-fighting public companies like Eli Lilly, Exelixis, Moderna, and Pfizer.

29 stocks4 etfs

Stocks

ADRO

Aduro BioTech

EXAS

Exact Sciences

CLVS

Clovis Oncology

INO

Inovio Pharmaceuticals

INCY

Incyte

ATRA

Atara Biotherapeutics

PGNX

Progenics Pharmaceuticals

KPTI

Karyopharm Therapeutics

NKTR

Nektar Therapeutics

EXEL

Exelixis

SGEN

Seattle Genetics

MRK

Merck

AGIO

Agios Pharmaceuticals

BDX

Becton, Dickinson and Co.

BMY

Bristol-Myers

JNJ

Johnson & Johnson

ABT

Abbott Labs

BLUE

bluebird bio

NVAX

Novavax

HTBX

Heat Biologics

AMGN

Amgen

PFE

Pfizer

REGN

Regeneron Pharmaceuticals

DVAX

Dynavax Technologies

LLY

Eli Lilly

CELG

Celgene

GILD

Gilead Sciences

MRNA

Moderna

VXRT

Vaxart

ETFs

XBI

SPDR S&P Biotech ETF

VHT

Vanguard Health Care ETF

XLV

Health Care Select Sector SPDR Fund

CNCR

Loncar Cancer Immunotherapy ETF

Public makes the stock market social. Follow other investors, discover companies to believe in, invest with any amount of money.

Invest in Apple